Charles Wartchow
Novartis (United States)(US)NovaBay Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, RNA and protein synthesis mechanisms, Ubiquitin and proteasome pathways, interferon and immune responses, Antenna Design and Analysis
Most-Cited Works
- → Label-Free Detection of Biomolecular Interactions Using BioLayer Interferometry for Kinetic Characterization(2009)367 cited
- → Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogeneous immunoassay method(1996)253 cited
- → A novel antiangiogenesis therapy using an integrin antagonist or anti–Flk-1 antibody coated 90Y-labeled nanoparticles(2004)159 cited
- → Biosensor-based small molecule fragment screening with biolayer interferometry(2011)142 cited
- → Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy(2023)141 cited
- → Metal Impurities Cause False Positives in High-Throughput Screening Campaigns(2012)119 cited